[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![OzmosiHealth Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1055982930.png) Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2623 followers
Created: 2023-10-30 20:35:20 UTC

Pharma/Biotech Highlights:

$MNKD: MannKind expands patent portfolio with Clofazimine.
$PHAT: FDA approves Phathom's Vonoprazan tablets.
$BMY: EMA approves Bristol Myers Squibb's Opdivo.
$DCPH: Positive Phase X results for Vimseltinib.

![](https://pbs.twimg.com/media/F9tv0RRXEAA_pst.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1719090631694324021/c:line.svg)

**Related Topics**
[$dcph](/topic/$dcph)
[$phat](/topic/$phat)
[$mnkd](/topic/$mnkd)
[$bmy](/topic/$bmy)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/OzmosiHealth/status/1719090631694324021)